Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Healthcare Biotechnology Cannabis Health Care
Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Lifeist Wellness Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by whisky11on Mar 25, 2022 7:54am
78 Views
Post# 34544350

Working capital position of $16.4 million at year end

Working capital position of $16.4 million at year end
  • EBITDA improved substantially by narrowing losses to $2.8 million in Q4 2021 (compared to a $5.7 million loss in Q4 2020 and a $5.4 million loss in the third quarter ended August 30, 2021) noting that Q4 2021 EBITDA loss results are net of incremental investments into emerging businesses including nutraceuticals.
  • Working capital position of $16.4 million at year end remains strong.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities